expec4v
Vaccineexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2015 (NCT02546960)
Timeline
Indications
Mechanism of action
- Escherichia coliImmunity, active
Escherichia coli immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- expec4v
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03819049 | Phase 1/Phase 2 (Phase 2) | Jun 3, 2019 | Janssen Pharmaceutica NV |
| NCT03500679 | Phase 2 | May 9, 2018 | Johnson and Johnson |
| NCT02748967 | Phase 1 | Apr 1, 2016 | Janssen Pharmaceutica NV, Johnson and Johnson |
| NCT02546960 | Phase 2 | Nov 1, 2015 | Johnson and Johnson |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johnson and Johnson | For profit | 3 | 3 | 2 | 2015 |
| Janssen Pharmaceutica NV | For profit | 2 | 1 | 2 | 2016 |
2 organizations
Page 1 / 1